Latest VTGN reports update at 2024-02-13: 2023-Q4 ∙ 2022-Q4
  1. Home
  2. Stock quotes
  3. VistaGen Therapeutics
  4. Financial Ratios
VistaGen Therapeutics logo
VistaGen Therapeutics VTGN
$ 4.48 0.67%
mail-toReport an Error

VistaGen Therapeutics Financial Ratios 2011-2024 | VTGN

Annual Financial Ratios VistaGen Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

 -1.0 -1.2 -0.9 -0.9 -1.2 -1.0 -1.5 -0.3 -0.8 -3.6 -1.2 -3.0 -

P/S

 68.8 64.7 26.4 - - - 11.9 - - - 79.5 27.4 -

EPS

 -1.7 -1.4 -1.6 -0.5 -0.9 -1.1 -1.5 -29.1 -10.5 -2.7 -1.3 - -

EV (Enterprise Value)

 4.48 M -46.6 M -77.4 M 29.4 M 24.4 M 7.87 M 15.1 M 18.6 M 31.4 M 23.6 M 28.7 M 42.8 M -139 K

EBITDA per Share

 -1.69 -1.39 -1.55 -0.472 -0.857 -1.02 -1.35 -10.1 -5.09 -4.53 -7.46 -12.2 -

EV/EBITDA

 0.0 -0.9 -0.7 -0.3 -1.2 -0.8 -3.7 -3.5 -3.1 -4.4 -

PEG

 -0.03 -0.04 -0.08 0.02 0.06 0.04 0.02 -0.0 -0.0 0.04 -0.02 -0.0 -

P/B

 1.0 0.2 0.1 -3.4 4.3 2.0 24.2 -5.0 -0.5 -0.8 -1.3 -6.5 -

P/CF

 -0.2 -0.3 -0.8 -1.2 -2.1 -1.5 -2.0 -3.1 -3.9 -4.9 -4.4 -10.2 -

ROE %

 -101.22 -15.08 -11.45 362.59 -347.55 -207.41 -1665.39 1586.07 67.59 23.19 102.63 213.99 -

ROA %

 -57.98 -13.08 -9.73 -359.89 -175.49 -127.20 -276.26 -4770.71 -5148.61 -1125.41 -1461.91 -3574.21 -

ROCE %

 -74.08 -14.18 -10.12 -693.14 -219.04 -144.60 -437.10 2217.69 39.59 101.76 443.14 318.40 -

Current Ratio

 2.3 7.5 6.6 0.6 4.9 7.6 2.5 0.5 0.0 0.0 0.3 0.1 -

DSO

 - - - - - - - - - - - 28.9 -

DIO

 - - - - - - - - - - - - -

DPO

 - - - - - - - - - - - - -

Operating Cycle

 - - - - - - - - - - - - -

Cash Conversion Cycle

 - - - - - - - - - - - - -

All numbers in USD currency

Quarterly Financial Ratios VistaGen Therapeutics

2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

 -0.22 -0.66 -0.94 - -1.42 -2.54 -2.87 -0.08 -0.05 -0.16 -0.11 -0.2 -0.07 -0.07 -0.05 -0.07 -0.15 -0.15 -0.13 -0.15 -0.24 -0.24 -0.3 -0.19 -0.25 -0.53 -0.28 -0.28 -0.34 -0.34 -0.42 -0.51 -1.95 -5.26 -5.26 -4.24 -0.84 -0.84 -1.58 -1.57 0.12 0.12 -1.35 0.01 -0.85 -1.11 -0.11 - - - - -

EBITDA per Share

 - - -0.94 - -1.41 -2.52 -2.87 -0.08 -0.05 -0.16 -0.11 -0.04 -0.07 -0.07 -0.05 -0.06 -0.14 -0.14 -0.12 -0.15 -0.23 -0.23 -0.29 -0.18 -0.21 -0.5 -0.25 -0.25 -0.31 -0.31 -0.38 -0.39 -1.21 -1.29 -3.3 -1.24 -0.86 -0.83 -0.85 - -1.3 -1.31 -1.12 - -0.1 -0.11 -0.1 -0.09 -0.17 -0.18 -0.12 -0.31

ROE %

 -171.64 -213.70 -254.27 -149.21 -175.00 -140.96 -120.43 -86.53 -67.50 -59.97 -27.09 -96.15 -33.68 69.78 173.24 398.32 -39.36 -563.50 -1087.64 -1421.00 -1098.01 -700.96 24.30 583.95 275.06 202.43 -161.06 -584.65 -150.72 85.52 312.10 608.35 686.00 557.80 402.06 169.26 61.11 53.86 46.55 45.64 8.59 60.41 144.06 162.96 196.44 240.23 209.20 210.01 185.34 51.58 31.93 7.33

ROA %

 -99.23 -127.25 -154.59 -109.49 -131.84 -110.62 -98.59 -72.37 -55.75 -48.96 -44.18 -90.20 -138.63 -245.61 -287.71 -275.45 -265.60 -249.72 -262.67 -311.52 -303.36 -228.51 -338.24 -341.12 -365.97 -389.77 -236.43 -178.90 -316.61 -378.42 -451.92 -820.70 -11568.97 -11882.48 -12053.20 -11913.29 -2692.98 -2232.94 -1918.87 -1992.67 -195.56 -1871.89 -3160.63 -3125.77 -3403.32 -2892.62 -2473.70 -2304.43 -2842.38 -837.56 -133.94 -745.09

ROCE %

 -119.39 -157.81 -191.02 -128.59 -152.82 -126.94 -110.05 -91.38 -73.12 -65.58 -36.98 -40.65 -134.77 -378.87 -650.72 -748.11 -756.04 -636.40 -495.67 -477.50 -411.00 -303.75 -848.78 -902.67 -957.55 -1001.21 -370.55 -256.06 84.27 2546.11 3111.18 3505.44 3272.16 886.81 389.37 58.93 74.00 106.18 139.88 167.95 169.91 212.40 237.66 234.05 174.02 245.57 219.84 221.66 260.42 50.39 46.80 6.39

Current Ratio

 16.8 6.4 1.8 2.3 3.3 3.7 4.6 7.5 8.6 5.1 5.7 6.6 7.1 1.3 0.5 0.5 0.5 0.7 1.1 2.0 1.3 1.8 1.6 2.6 3.6 0.6 0.8 1.2 1.8 2.4 3.4 0.2 0.6 0.6 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.0

DSO

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - 45.6 - - - - - - - - - - - - - - - - 0.7 24.5 25.9 3076.0 5239.0 27.5 -

DIO

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - 45.6 - - - - - - - - - - - - - - - - 0.7 24.5 25.9 3076.0 5239.0 27.5 -

Cash Conversion Cycle

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - 45.6 - - - - - - - - - - - - - - - - 0.7 24.5 25.9 3076.0 5239.0 27.5 -

All numbers in USD currency